Search Results - "MANZUR, A"

Refine Results
  1. 1

    Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy by Ricotti, Valeria, Ridout, Deborah A, Scott, Elaine, Quinlivan, Ros, Robb, Stephanie A, Manzur, Adnan Y, Muntoni, Francesco

    “…Objective To assess the current use of glucocorticoids (GCs) in Duchenne muscular dystrophy in the UK, and compare the benefits and the adverse events of daily…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Glucocorticoid corticosteroids for Duchenne muscular dystrophy by Manzur, A Y, Kuntzer, T, Pike, M, Swan, A

    Published in Cochrane database of systematic reviews (01-01-2008)
    “…Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy of childhood. This incurable disease is characterised by muscle wasting and loss of…”
    Get more information
    Journal Article
  4. 4

    Diagnosis and new treatments in muscular dystrophies by Manzur, A Y, Muntoni, F

    “…Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) and limb girdle muscular dystrophies (LGMD) represent a significant proportion of paediatric…”
    Get full text
    Journal Article Book Review
  5. 5

    RYR1 mutations are a common cause of congenital myopathies with central nuclei by Wilmshurst, J.M., Lillis, S., Zhou, H., Pillay, K., Henderson, H., Kress, W., Müller, C.R., Ndondo, A., Cloke, V., Cullup, T., Bertini, E., Boennemann, C., Straub, V., Quinlivan, R., Dowling, J.J., Al- Sarraj, S., Treves, S., Abbs, S., Manzur, A.Y., Sewry, C.A., Muntoni, F., Jungbluth, H.

    Published in Annals of neurology (01-11-2010)
    “…Objective Centronuclear myopathy (CNM) is a rare congenital myopathy characterized by prominence of central nuclei on muscle biopsy. CNM has been associated…”
    Get full text
    Journal Article
  6. 6

    Update on the management of Duchenne muscular dystrophy by Manzur, A Y, Kinali, M, Muntoni, F

    Published in Archives of disease in childhood (01-11-2008)
    “…Duchenne muscular dystrophy (DMD) is familiar to paediatricians as the most common childhood muscular dystrophy and leads to severe disability and early death…”
    Get full text
    Journal Article
  7. 7

    Natural history of Ullrich congenital muscular dystrophy by NADEAU, A, KINALI, M, MUNTONI, F, MAIN, M, JIMENEZ-MALLEBRERA, C, ALOYSIUS, A, CLEMENT, E, NORTH, B, MANZUR, A. Y, ROBB, S. A, MERCURI, E

    Published in Neurology (07-07-2009)
    “…To describe the course, complications, and prognosis of Ullrich congenital muscular dystrophy (UCMD), with special reference to life-changing events, including…”
    Get full text
    Journal Article
  8. 8

    Muscle histology vs MRI in Duchenne muscular dystrophy by KINALI, M, ARECHAVALA-GOMEZA, V, QUINLIVAN, R. M, GOSALAKKAL, J. A, JAYAWANT, S, NADEAU, A, HUGHES-CARRE, L, MANZUR, A. Y, MERCURI, E, MORGAN, J. E, STRAUB, V, BUSHBY, K, CIRAK, S, SEWRY, C, RUTHERFORD, M, MUNTONI, F, GLOVER, A, GUGLIERI, M, FENG, L, HOLLINGSWORTH, K. G, HUNT, D, JUNGBLUTH, H, ROPER, H. P

    Published in Neurology (25-01-2011)
    “…There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being…”
    Get full text
    Journal Article
  9. 9

    A new respiratory scoring system for evaluation of respiratory outcomes in children with spinal muscular atrophy type1 (SMA1) on SMN enhancing drugs by Edel, L, Grime, C, Robinson, V, Manzur, A, Abel, F, Munot, P, Ridout, D, Scoto, M, Muntoni, F, Chan, E

    Published in Neuromuscular disorders : NMD (01-04-2021)
    “…•The first objective measure to enable tracking of respiratory function for type 1.•Scoring system focuses on ventilation, secretion management and subtype.•By…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Methicillin-resistant Staphylococcus aureus in long-term-care facilities by Manzur, A., Gudiol, F.

    Published in Clinical microbiology and infection (01-12-2009)
    “…Owing to a high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) among residents, long-term-care facilities (LTCFs) have become substantial…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Diagnosis and new treatments in muscular dystrophies by Manzur, A Y, Muntoni, F

    “…Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD) and limb girdle muscular dystrophies (LGMD) represent a significant proportion of paediatric…”
    Get full text
    Journal Article
  14. 14

    SEPN1-related myopathies: Clinical course in a large cohort of patients by SCOTO, M, CIRAK, S, LONGMAN, C, CHOW, G, PANE, M, MAIN, M, HANNA, M. G, BUSHBY, K, SEWRY, C, ABBS, S, MERCURI, E, MUNTONI, F, MEIN, R, FENG, L, MANZUR, A. Y, ROBB, S, CHILDS, A.-M, QUINLIVAN, R. M, ROPER, H, JONES, D. H

    Published in Neurology (14-06-2011)
    “…To assess the clinical course and genotype-phenotype correlations in patients with selenoprotein-related myopathy (SEPN1-RM) due to selenoprotein N1 gene…”
    Get full text
    Journal Article
  15. 15

    Breakthrough candidaemia in the era of broad-spectrum antifungal therapies by Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J.M., Ayats, J., Carratalà, J.

    Published in Clinical microbiology and infection (01-02-2016)
    “…We aimed to assess the characteristics, treatment, risk factors and outcome of patients with breakthrough candidaemia (BrC) in the era of broad-spectrum…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Congenital myopathies – Clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom by Maggi, L, Scoto, M, Cirak, S, Robb, S.A, Klein, A, Lillis, S, Cullup, T, Feng, L, Manzur, A.Y, Sewry, C.A, Abbs, S, Jungbluth, H, Muntoni, F

    Published in Neuromuscular disorders : NMD (01-03-2013)
    “…Abstract The congenital myopathies are a group of inherited neuromuscular disorders mainly defined on the basis of characteristic histopathological features…”
    Get full text
    Journal Article
  20. 20

    Clinical spectrum, treatment and outcome of children with suspected diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy by Silwal, A., Pitt, M., Phadke, R., Mankad, K., Davison, J.E., Rossor, A., DeVile, C., Reilly, M.M., Manzur, A.Y., Muntoni, F., Munot, P.

    Published in Neuromuscular disorders : NMD (01-09-2018)
    “…•The diagnosis of CIDP can be challenging.•In our cohort 52% were diagnosed as CIDP on re-evaluation.•Cranial nerve abnormality is rare and may be only…”
    Get full text
    Journal Article